FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in ... (The San Francisco Examiner)
NEW PROVIDENCE, N.J., March 4 /PRNewswire/ -- Aerocrine, Inc. ( www.aerocrine.com ) today announced that NIOX MINO ( www.nioxmino.com ), a hand- held point-of-care device for the measurement of airway inflammation, has been 510(k) cleared by the U.S. Food and Drug Administration (FDA). Physicians in the U.S. now have a highly accurate, non-invasive and convenient technology that is ...